Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: A phase II prospective, randomised study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 10, 2015, Pages 1158-1162

  Iuchi, Toshihiko ^a   Kuwabara, Kiyoto ^a   Matsumoto, Minako ^a   Kawasaki, Koichiro ^a   Hasegawa, Yuzo ^a   Sakaida, Tsukasa ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; FOSPHENYTOIN SODIUM; PHENYTOIN; ANTICONVULSIVE AGENT; PIRACETAM;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BLOOD TOXICITY; BRAIN TUMOR; CONTROLLED STUDY; CRANIOTOMY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPONATREMIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; SEIZURE; TREATMENT OUTCOME; ADOLESCENT; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BRAIN NEOPLASMS; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; MIDDLE AGED; NEUROSURGERY; POSTOPERATIVE COMPLICATIONS; SEIZURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BRAIN NEOPLASMS; COHORT STUDIES; CRANIOTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PHENYTOIN; PIRACETAM; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84942322154     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-308584     Document Type: Article

References (31)

1. Hildebrand J, Lecaille C, Perennes J, et al. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 2005;65:212-15.
2. van Breemen MS, Rijsman RM, Taphoorn MJ, et al. Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 2009;256:1519-26.
3. North JB, Penhall RK, Hanieh A, et al. Phenytoin and postoperative epilepsy. A double-blind study. J Neurosurg 1983;58:672-7.
4. Franceschetti S, Binelli S, Casazza M, et al. Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir 1990;103:47-51.
5. Glantz MJ, Cole BF, Friedberg MH, et al. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996;46:985-91.
6. Forsyth PA, Weaver S, Fulton D, et al. Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 2003;30:106-12.
7. Mahaley MS Jr, Dudka L. The role of anticonvulsant medications in the management of patients with anaplastic gliomas. Surg Neurol 1981;16:399-401.
8. Byrne TN, Cascino TL, Posner JB. Brain metastasis from melanoma. J Neurooncol 1983;1:313-17.
9. Boarini DJ, Beck DW, VanGilder JC. Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 1985;16:290-2.
10. Cohen N, Strauss G, Lew R, et al. Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 1988;6:1621-4.
11. Hagen NA, Cirrincione C, Thaler HT, et al. The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 1990;40:158-60.
12. Moots PL, Maciunas RJ, Eisert DR, et al. The course of seizure disorders in patients with malignant gliomas. Arch Neurol 1995;52:717-24.
13. Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54:1886-93.
14. Foy PM, Copeland GP, Shaw MD. The incidence of postoperative seizures. Acta Neurochir 1981;55:253-64.
15. Shaw MD, Foy PM. Epilepsy after craniotomy and the place of prophylactic anticonvulsant drugs: Discussion paper. J R Soc Med 1991;84:221-3.
16. Nossek E, Matot I, Shahar T, et al. Failed awake craniotomy: a retrospective analysis in 424 patients undergoing craniotomy for brain tumor. J Neurosurg 2013;118:243-9.
17. Hefti M, Albert I, Luginbuehl V. Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells. J Neurooncol 2012;108:443-50.
18. Wu AS, Trinh VT, Suki D, et al. A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 2013;118:873-83.
19. European Organization for Research and Treatment of Cancer: Common Toxicity Criteria (CTC). http://www.eortc.be/services/doc/ctc/default.htm
20. Lwu S, Hamilton MG, Forsyth PA, et al. Use of perioperative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience. J Neurooncol 2010;96:403-8.
21. Sughrue ME, Rutkowski MJ, Chang EF, et al. Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article. J Neurosurg 2011;114:705-9.
22. Milligan TA, Hurwitz S, Bromfield EB. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 2008;71:665-9.
23. Hardesty DA, Sanborn MR, Parker WE, et al. perioperative seizure incidence and risk factors in 223 pediatric brain tumor patients without prior seizures. J Neurosurg Pediatr 2011;7:609-15.
24. Kuijlen JM, Teernstra OP, Kessels AG, et al. Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure 1996;5:291-8.
25. Fleishaker JC, Pearson LK, Peters GR. Phenytoin causes a rapid increase in 6 beta-hydroxycortisol urinary excretion in humans - a putative measure of CYP3A induction. J Pharm Sci 1995;84:292-4.
26. Restrepo JG, Garcia-Martín E, Martínez C, et al. Polymorphic drug metabolism in anaesthesia. Curr Drug Metab 2009;10:236-46.
27. Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin (Part I). Clin Pharmacokinet 1990;18:37-60.
28. Kern K, Schebesch KM, Schlaier J, et al. Levetiracetam compared to phenytoin for the prevention of postoperative seizures after craniotomy for intracranial tumours in patients without epilepsy. J Clin Neurosci 2012;19:99-100.
29. Gokhale S, Khan SA, Agrawal A, et al. Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures. Asian J Neurosurg 2013;8:169-73.
30. Toublanc N, Lacroix BD, Yamamoto J. Development of an integrated population pharmacokinetic model for oral levetiracetam in populations of various ages and ethnicities. Drug Metab Pharmacokinet 2014;29:61-8.
31. Fuller KL, Wang YY, Cook MJ, et al. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Epilepsia 2013;54:45-57.